Journal of Korean Medical classics (대한한의학원전학회지)

The Society of Korean Medical Classics (대한한의학원전학회)
권호 표지
DOI QR코드

DOI QR Code

A Study on The Efficacy of Cannabis Sativa According to Different Parts

대마(大麻)의 부위별 효능(效能)에 대한 고찰

  • Lim Seok-hyeon (Graduate School, College of Korean Medicine, Kyunghee University) ;
  • Jeong Chang-hyun (Dept. of Korean Medical Classics, College of Korean Medicine, Kyunghee University) ;
  • Baik Yousang (Dept. of Korean Medical Classics, College of Korean Medicine, Kyunghee University)
  • Received : 2023.05.09
  • Accepted : 2023.05.16
  • Published : 2023.05.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : This study aims to examine the efficacy and application of Cannabis according to its parts. Methods : Contents on efficacy, treatment, and application of Cannabis in Material Medica and other texts of East Asian Medicine were collected and interpreted to deduce each characteristic. Results : Cannabis was found to be applicable to various wind symptoms and wind stroke, various pain and injuries, skin diseases, blockage or leaking of urine or feces, disease related to genitalia and anus, chronic ague, women's disease related to menstruation, birth, pregnancy, and to have the effects of heightening perceptive and sensory organs, detoxification and anesthesia, stimulating hair growth, and eradicating parasites. It drives out wind-heat pathogenic qi, circulates qi and blood, which allowed it to be applied not only to blockages but to symptoms of leakage. In other words, Cannabis was used when both excess and deficiency diseases were present, the former caused by acute blockage and the latter accompanied by stagnation. Conclusions : Based on the findings of this study, future researches on the efficacy and application of Cannabis could be done more systematically. In line with recent trend of wide application of medical Cannabis, we hope for it to be more actively used in the field of East Asian Medicine based on objective evidence.

Keywords

References

  1. 동양의학대사전편찬위원회 편저. 동양의학대 사전. 서울. 경희대학교 출판국. 1999 
  2. 新文豊出版公司 編. 김창민 外譯. 完譯 中藥大辭典. 서울. 도서출판 정담. 1998. 
  3. 郭麗 外 3人 共譯. 論炙甘草湯中麻仁. 四川中醫. 2015. 33(6). 
  4. 譚歌, 呂翠霞. 炙甘草湯"麻仁"之我見. 長春中醫藥大學學報. 2018. 34(2). https://doi.org/10.13463/j.cnki.cczyy.2018.02.012 
  5. 李秋實, 孟瑩, 陳士林. 藥用大麻種質資源分類與研究策略. 中國中藥雜志. 2019. 44(20). https://doi.org/10.19540/j.cnki.cjcmm.20190916.101 
  6. 白雲俊 外 3人 共譯. 藥用大麻起源及其早期傳播. 中草藥. 2019. 50(20). https://doi.org/10.7501/j.issn.0253-2670.2019.20.033 
  7. 史仁傑. 脾約證及麻仁丸考析. 江蘇中醫藥. 2008. 40(5). https://doi.org/CNKI:SUN:JSZY.0.2008-05-011. 
  8. 謝惠素. 炙甘草湯方"麻仁"析. 遼寧中醫雜志. 2011. 38(11). https://doi.org/10.13192/j.ljtcm.2011.11.86.xiehs.063 
  9. 常麗 外 8人 共譯. 基於專利分析的大麻研發態勢及技術構成. 生物技術通報. 2018. 34(12). https://doi.org/10.13560/j.cnki.biotech.bull.1985.2018-0663 
  10. 손호용, 김문년, 김영민. 대마 생물산업의 현황과 전망. 생명과학회지 2021. 31(7). https://doi.org/10.5352/JLS.2021.31.7.677 
  11. 申永和. 麻子仁丸應用四則. 中國民間療法. 2002. 10(10). https://doi.org/10.19621/j.cnki.11-3555/r.2002.10.065 
  12. 於宛彤 外 5人 共譯. 藥用大麻活性成分產品開發及育種研究進展. 中國實驗方劑學雜志. 2023. 29(3). https://doi.org/10.13422/j.cnki.syfjx.20220556 
  13. 王秋月, 盧芳, 劉樹民. 大麻及大麻素藥用價值的現代研究進展. 中藥藥理與臨床. 2020. 36(4). https://doi.org/10.13412/j.cnki.zyyl.2020.04.032 
  14. 苑佳玉 外 3人 共譯. 大麻的成癮性和潛在的藥用價值. 中國藥物依賴性雜志. 2017. 26(5). https://doi.org/0.13936/j.cnki.cjdd1992.2017.05.002 
  15. 유요안, 전용일, 배정생. 주요 국가의 대마합법화 동향과 국내 시사점. 東北亞法硏究. 2022. 15(3). https://doi.org/10.19035/nal.2022.15.3.23 
  16. 張喬會 外 3人 共譯. 火麻仁研究概述. 湖北農業科學. 2019. 58(21). https://doi.org/10.14088/j.cnki.issn0439-8114.2019.21.002 
  17. 張明發 外 3人 共譯. 火麻仁的消化系統藥理研究. 藥學實踐雜志. 1997. 15(5). https://doi.org/CNKI:SUN:YXSJ.0.1997-05-003. 
  18. 張明發 外 3人 共譯. 火麻仁的鎮痛抗炎抗血栓形成作用研究. 基層中藥雜志. 1999. 13(1). https://doi.org/10.13728/j.1673-6427.1999.01.01 
  19. 張世鵬 外 6人 共譯. 火麻仁化學成分研究. 沈陽藥科大學學報. 2023. 40(4). https://doi.org/10.14066/j.cnki.cn21-1349/r.2021.0890 
  20. 張漢文 外 3人 共譯. 基於中藥配伍的火麻仁藥理作用研究進展. 中國醫院藥學雜志. 2022. 42(6). https://doi.org/10.13286/j.1001-5213.2022.06.16. 
  21. 周路紅, 王蓓, 張曉薇. 繼承與創新:麻仁潤腸茶的研制. 中國中醫藥現代遠程教育. 2022. 20(19). https://doi.org/10.3969/j.issn.1672-2779.2022.19.032 
  22. 朱文翔 外 8人 共譯. 芻議太陽陽明脾約及麻子仁丸三者的聯系. 中華中醫藥雜志. 2017.32(9). https://doi.org/CNKI:SUN:BXYY.0.2017-09-016. 
  23. 朱文翔 外 6人 共譯. 麻子仁丸病機及方證探析. 環球中醫藥. 2017. 10(8). https://doi.org/10.3969/j.issn.1674-1749.2017.08.032 
  24. 陈修源. 火麻仁無補虛之功. 江西中医药. 1988. (4). https://doi.org/CNKI:SUN:JXZY.0.1988-04-036. 
  25. 陈锐张平. 炙甘草汤中麻仁的研究进展. 中國社區醫師. 2004. 6(7). https://doi.org/CNKI:SUN:ZGSQ.0.2004-07-114. 
  26. 肖相如. 脾約不是麻子仁丸證. 河南中醫. 2009. 29(11). https://doi.org/10.16367/j.issn.1003-5028.2009.11.004 
  27. 祝慶明 外 5人 共譯. 《神農本草經》藥物解讀-麻子. 中國中醫藥現代遠程教育. 2017. 15(23). https://doi.org/10.3969/j.issn.1672-2779.2017.23.033 
  28. 한경선, 이명종, 김호준. 의료용 대마의 이해 및 법적 규제에 대한 고찰: 대마의 치료적,학술적 필요성 제고. 한방비만학회지. 2016. 16(2). https://doi.org/10.15429/jkomor.2016.16.2.124 
  29. 邢俊波 外 3人 共譯. 大麻花葉本草考證. 綠色科技. 2020. (7). https://doi.org/10.16663/j.cnki.lskj.2020.07.031 
  30. Carni Lipson Feder. et al. Fertilization Following Pollination Predominantly Decreases Phytocannabinoids Accumulation and Alters the Accumulation of Terpenoids in Cannabis Inflorescences. Frontiers in Plant Science. 2021. vol 12. https://doi.org/10.3389/fpls.2021.753847 
  31. Chayasirisobhon S. Mechanisms of Action and Pharmacokinetics of Cannabis. Perm J. 2020 . 25. https://doi.org/10.7812/TPP/19.200 
  32. Jin D. et al. Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots. Frontier in Plant Science. 2021 .12. https://doi.org/10.3389/fpls.2021.699530 
  33. Kruger M, van Eeden T, Beswa D. Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods-Historical and Developmental Aspects. Plants. 2022. 11(23). https://doi.org/10.3390/plants11233330 
  34. McPartland JM, Small E. A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives. PhytoKeys. 2020. 144. https://doi.org/10.3897/phytokeys.144.46700 
  35. Nandakumara D. Sarma. et al. Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attribute. Journal Of Natural Products. 2020. 83. https://dx.doi.org/10.1021/acs.jnatprod.9b01200 
  36. Natasha R. Ryz, David J. Remillard, and Ethan B. Russo.Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. Cannabis and Cannabinoid Research. Dec 2017. http://doi.org/10.1089/can.2017.0028 
  37. Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018. 31(6). https://doi.org/10.1097/WCO.0000000000000622 
  38. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013. 310(17). https://doi.org/10.1001/jama.2013.280319 
  39. Upton, R. et al. Cannabis inflorescence: cannabis spp.; standards of identity, analysis, and quality control. California. American Herbal Pharmacopoeia. 2014. 
  40. Yang Y, Lewis MM, Bello AM, Wasilewski E, Clarke HA, Kotra LP. Cannabis sativa (Hemp) Seeds, Δ 9-Tetrahydrocannabinol, and Potential Overdose. Cannabis Cannabinoid Res. 2017. 2(1). https://doi.org/10.1089/can.2017.0040 
  41. A+醫學百科 홈페이지. 2006 [cited 1 May. 2023] : Available from: URL: http://www.a-hospital.com/w 
  42. 위키백과. 2001 [cited 1 May. 2023] : Available from: URL: https://ko.wikipedia.org/wiki https://en.wikipedia.org/wiki 
  43. 百度百科(바이두 백과사전). 2000 [cited 1 May. 2023] : Available from: URL: https://baike.baidu.com/